Premium Nahrungsergänzungsmittel | artgerecht

Xenobiotic Bioreaction – Biotransformation Explained

The xenobiotic bioreaction describes the metabolic process by which the body chemically transforms and eliminates foreign substances such as drugs, environmental toxins, and chemicals.

Regular tips about health Regular tips about health

Things worth knowing about "Xenobiotic bioreaction"

The xenobiotic bioreaction describes the metabolic process by which the body chemically transforms and eliminates foreign substances such as drugs, environmental toxins, and chemicals.

What is a Xenobiotic Bioreaction?

The term xenobiotic bioreaction refers to the biochemical transformation processes that foreign substances – known as xenobiotics – undergo within the human body. Xenobiotics include drugs, pesticides, environmental pollutants, food additives, and industrial chemicals. The primary goal of these reactions is to convert lipophilic (fat-soluble) foreign compounds into more water-soluble forms that can be efficiently excreted by the body.

Phases of the Xenobiotic Bioreaction

The biotransformation of xenobiotics classically occurs in three distinct phases:

Phase I – Functionalization Reactions

In Phase I, xenobiotics are chemically modified through oxidation, reduction, or hydrolysis. The central enzyme system involved is the cytochrome P450 (CYP) system, predominantly located in the liver. These reactions introduce or expose functional groups (e.g., hydroxyl groups), making the molecule more reactive and preparing it for the next phase.

Phase II – Conjugation Reactions

In Phase II, the reactive groups generated in Phase I are coupled with endogenous molecules such as glucuronic acid, sulfate, glutathione, or glycine. This conjugation significantly increases water solubility, facilitating the excretion of the transformed substance.

Phase III – Transport Reactions

Phase III involves active transport mechanisms in which conjugated metabolites are exported from cells via transport proteins (e.g., ABC transporters) and ultimately excreted via the kidneys (urine) or the liver (bile).

Organs Involved

The xenobiotic bioreaction primarily takes place in the following organs:

Liver: The primary metabolic organ for xenobiotics, containing the highest concentration of biotransformation enzymes
Small intestine: The first barrier after oral ingestion (first-pass effect)
Kidneys: Excretion of water-soluble metabolites
Lungs: Metabolism of inhaled substances
Skin: Local biotransformation of topically applied compounds

Clinical Significance

The xenobiotic bioreaction has major clinical relevance in several areas:

Drug interactions: Many medications compete for the same CYP enzymes, which can lead to elevated or reduced drug plasma levels and altered therapeutic effects.
Toxicity: Phase I reactions can convert harmless substances into reactive metabolites that are cytotoxic or carcinogenic (e.g., in acetaminophen overdose).
Genetic variability: Polymorphisms in CYP genes result in individual differences in metabolic rates, classifying people as slow or rapid metabolizers.
Liver disease: Impaired liver function can reduce biotransformation capacity, leading to accumulation of xenobiotics in the body.

Factors Influencing the Xenobiotic Bioreaction

Numerous factors can affect the activity of biotransformation enzymes:

Age (neonates and elderly individuals have reduced enzyme activity)
Genetic factors (enzyme polymorphisms)
Diet (e.g., grapefruit juice inhibits CYP3A4)
Comorbidities (e.g., liver disease, renal insufficiency)
Co-administration of other drugs or substances (enzyme induction or inhibition)

References

Klaassen, C.D. (ed.): Casarett and Doull's Toxicology: The Basic Science of Poisons. 9th edition. McGraw-Hill Education, 2019.
Zanger, U.M. & Schwab, M.: Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacology & Therapeutics, 138(1):103–141, 2013. PubMed PMID: 23333322.
Timbrell, J.A.: Principles of Biochemical Toxicology. 4th edition. Informa Healthcare, 2009.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.